Eris Lifesciences Ltd to Acquire Biocon Biologics Ltd Call Transcript
Ladies and gentlemen, good day, and welcome to the Webcast of Eris Lifesciences Limited. We have with us on call today, Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director.
As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. All the participants are requested to restrict the discussion to the deals announced today. Please note, this webcast is being recorded. I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you and over to you, sir.
Good afternoon, everybody. Welcome to this webcast. We are here to talk about the two announcements we have made today. Eris proposes to acquire the India branded formulations business of Biocon Biologics and 19% stake in Swiss Parenterals from Eris Promoter Group. At the outset,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |